Annual EBITDA
$4.25B$411.00M-8.83%
Summary
- Current Value
- As of today, REGN annual EBITDA is $4.25B, down -8.83% on
- Historical Performance
- REGN annual EBITDA is down -25.87% over the past 3 years, up +11.36% over the past 5 years
- All-Time High Comparison
- REGN annual EBITDA is currently -54.02% below its historical high of $9.23B set on
- 3-Year Low Comparison
- REGN annual EBITDA is at its 3-year low
- Sector Comparison
- REGN annual EBITDA is higher than 97.94% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $4.25B | -8.8% | -25.9% | +11.4% | +5558.3% | |
| Quarterly EBITDA | $1.04B | -9.5% | -26.3% | -15.1% | +10000.0% | |
| TTM EBITDA | $4.25B | -7.7% | -22.4% | +11.4% | +5573.6% | |
| Price | $782.38 | +14.1% | +4.5% | +66.3% | +1987.5% | |
| PE Ratio | 18.82 | +5.1% | -3.9% | +22.8% | – | |
| Annual Revenue | $14.34B | +1.0% | +17.8% | +68.8% | +3024.3% | |
| Annual EPS | $41.48 | +8.2% | +8.5% | +35.9% | +3392.2% | |
| $3.69B | -11.5% | -31.4% | +3.3% | +3888.6% | ||
| Annual Net Income | $4.50B | +2.1% | +3.8% | +28.2% | +4412.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $5.73B | N/A | -25.9% |
| 5Y | $9.23B | -54.0% | |
| All | $9.23B | -54.0% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.25B | at low | |
| 5Y | $3.81B | N/A | +11.4% |
| All | -$174.08M | +2539.0% |
EBITDA History
FAQ
What is the current annual EBITDA of REGN?
As of today, REGN annual EBITDA is $4.25B
What is 1-year change in REGN annual EBITDA?
REGN annual EBITDA is down -8.83% year-over-year
What is 3-year change in REGN annual EBITDA?
REGN annual EBITDA is down -25.87% over the past 3 years
How far is REGN annual EBITDA from its all-time high?
REGN annual EBITDA is currently -54.02% below its historical high of $9.23B set on December 31, 2021
How does REGN annual EBITDA rank versus sector peers?
REGN annual EBITDA is higher than 97.94% of companies in Healthcare sector
When is REGN next annual earnings release?
As of today, the next annual earnings release for REGN has not been scheduled
Quarterly EBITDA
$1.04B$203.00M-16.28%
Summary
- Current Value
- As of today, REGN quarterly EBITDA is $1.04B, down -16.28% on
- Historical Performance
- REGN quarterly EBITDA is down -9.49% year-over-year, down -26.27% over the past 3 years
- All-Time High Comparison
- REGN quarterly EBITDA is currently -69.47% below its historical high of $3.42B set on
- 3-Year Low Comparison
- REGN quarterly EBITDA is +42.78% above its 3-year low of $730.90M reached on
- Sector Comparison
- REGN quarterly EBITDA is higher than 97.80% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.04B | -16.3% | -9.5% | -26.3% | -15.1% | |
| Annual EBITDA | $4.25B | – | -8.8% | -25.9% | +11.4% | |
| TTM EBITDA | $4.25B | -2.5% | -7.7% | -22.4% | +11.4% | |
| Price | $782.38 | +11.3% | +14.1% | +4.5% | +66.3% | |
| PE Ratio | 18.82 | +11.9% | +5.1% | -3.9% | +22.8% | |
| Quarterly Revenue | $3.88B | +3.5% | +2.5% | +13.8% | +60.3% | |
| Quarterly EPS | $7.86 | -42.3% | -2.6% | -25.2% | -23.3% | |
| $898.60M | -19.0% | -12.5% | -31.7% | -23.0% | ||
| Quarterly Net Income | $844.60M | -42.1% | -8.0% | -29.4% | -26.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.25B | -16.3% | |
| 3Y | $1.42B | N/A | -26.3% |
| 5Y | $3.42B | -69.5% | |
| All | $3.42B | -69.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $730.90M | +42.8% | |
| 3Y | $730.90M | +42.8% | |
| 5Y | $730.90M | +42.8% | |
| All | -$52.42M | +2091.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of REGN?
As of today, REGN quarterly EBITDA is $1.04B
What is REGN quarterly EBITDA most recent change?
REGN quarterly EBITDA was down -16.28% on December 31, 2025
What is 1-year change in REGN quarterly EBITDA?
REGN quarterly EBITDA is down -9.49% year-over-year
How far is REGN quarterly EBITDA from its all-time high?
REGN quarterly EBITDA is currently -69.47% below its historical high of $3.42B set on June 30, 2021
How does REGN quarterly EBITDA rank versus sector peers?
REGN quarterly EBITDA is higher than 97.80% of companies in Healthcare sector
When is REGN next earnings release?
The next earnings release for REGN is on
TTM EBITDA
$4.25B$109.40M-2.51%
Summary
- Current Value
- As of today, REGN TTM EBITDA is $4.25B, down -2.51% on
- Historical Performance
- REGN TTM EBITDA is down -7.65% year-over-year, down -22.44% over the past 3 years
- All-Time High Comparison
- REGN TTM EBITDA is currently -54.90% below its historical high of $9.41B set on
- 3-Year Low Comparison
- REGN TTM EBITDA is at its 3-year low
- Sector Comparison
- REGN TTM EBITDA is higher than 97.80% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.25B | -2.5% | -7.7% | -22.4% | +11.4% | |
| Annual EBITDA | $4.25B | – | -8.8% | -25.9% | +11.4% | |
| Quarterly EBITDA | $1.04B | -16.3% | -9.5% | -26.3% | -15.1% | |
| Price | $782.38 | +11.3% | +14.1% | +4.5% | +66.3% | |
| PE Ratio | 18.82 | +11.9% | +5.1% | -3.9% | +22.8% | |
| TTM Revenue | $14.34B | +0.7% | +1.0% | +17.8% | +68.8% | |
| TTM EPS | $41.56 | -0.5% | +8.6% | +8.7% | +35.5% | |
| $3.70B | -3.3% | -10.0% | -27.9% | +3.5% | ||
| TTM Net Income | $4.50B | -1.6% | +2.1% | +3.8% | +28.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.60B | N/A | -7.7% |
| 3Y | $5.47B | N/A | -22.4% |
| 5Y | $9.41B | -54.9% | |
| All | $9.41B | -54.9% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.25B | at low | |
| 3Y | $4.25B | at low | |
| 5Y | $3.81B | N/A | +11.4% |
| All | -$174.08M | +2539.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of REGN?
As of today, REGN TTM EBITDA is $4.25B
What is REGN TTM EBITDA most recent change?
REGN TTM EBITDA was down -2.51% on December 31, 2025
What is 1-year change in REGN TTM EBITDA?
REGN TTM EBITDA is down -7.65% year-over-year
How far is REGN TTM EBITDA from its all-time high?
REGN TTM EBITDA is currently -54.90% below its historical high of $9.41B set on March 31, 2022
How does REGN TTM EBITDA rank versus sector peers?
REGN TTM EBITDA is higher than 97.80% of companies in Healthcare sector
When is REGN next earnings release?
The next earnings release for REGN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- REGN Official Website www.regeneron.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/872589/000087258926000004/0000872589-26-000004-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm
- REGN Profile on Yahoo Finance finance.yahoo.com/quote/REGN
- REGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/regn